391 related articles for article (PubMed ID: 26224795)
1. Bromodomain-Containing Protein 4: The Epigenetic Origin of Pulmonary Arterial Hypertension.
Meloche J; Potus F; Vaillancourt M; Bourgeois A; Johnson I; Deschamps L; Chabot S; Ruffenach G; Henry S; Breuils-Bonnet S; Tremblay È; Nadeau V; Lambert C; Paradis R; Provencher S; Bonnet S
Circ Res; 2015 Aug; 117(6):525-35. PubMed ID: 26224795
[TBL] [Abstract][Full Text] [Related]
2. Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial Hypertension.
Meloche J; Lampron MC; Nadeau V; Maltais M; Potus F; Lambert C; Tremblay E; Vitry G; Breuils-Bonnet S; Boucherat O; Charbonneau E; Provencher S; Paulin R; Bonnet S
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1513-1523. PubMed ID: 28473439
[TBL] [Abstract][Full Text] [Related]
3. Role for DNA damage signaling in pulmonary arterial hypertension.
Meloche J; Pflieger A; Vaillancourt M; Paulin R; Potus F; Zervopoulos S; Graydon C; Courboulin A; Breuils-Bonnet S; Tremblay E; Couture C; Michelakis ED; Provencher S; Bonnet S
Circulation; 2014 Feb; 129(7):786-97. PubMed ID: 24270264
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J
Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target.
Archer SL; Marsboom G; Kim GH; Zhang HJ; Toth PT; Svensson EC; Dyck JR; Gomberg-Maitland M; Thébaud B; Husain AN; Cipriani N; Rehman J
Circulation; 2010 Jun; 121(24):2661-71. PubMed ID: 20529999
[TBL] [Abstract][Full Text] [Related]
7. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted.
Bonnet S; Rochefort G; Sutendra G; Archer SL; Haromy A; Webster L; Hashimoto K; Bonnet SN; Michelakis ED
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11418-23. PubMed ID: 17596340
[TBL] [Abstract][Full Text] [Related]
8. CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension.
Zhuang W; Lian G; Huang B; Du A; Gong J; Xiao G; Xu C; Wang H; Xie L
Mol Cell Biochem; 2019 May; 455(1-2):169-183. PubMed ID: 30511343
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.
Hong Z; Chen KH; DasGupta A; Potus F; Dunham-Snary K; Bonnet S; Tian L; Fu J; Breuils-Bonnet S; Provencher S; Wu D; Mewburn J; Ormiston ML; Archer SL
Am J Respir Crit Care Med; 2017 Feb; 195(4):515-529. PubMed ID: 27648837
[TBL] [Abstract][Full Text] [Related]
11. Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension.
Ruffenach G; Chabot S; Tanguay VF; Courboulin A; Boucherat O; Potus F; Meloche J; Pflieger A; Breuils-Bonnet S; Nadeau V; Paradis R; Tremblay E; Girerd B; Hautefort A; Montani D; Fadel E; Dorfmuller P; Humbert M; Perros F; Paulin R; Provencher S; Bonnet S
Am J Respir Crit Care Med; 2016 Nov; 194(10):1273-1285. PubMed ID: 27149112
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism.
Liu Y; Sun Z; Zhu J; Xiao B; Dong J; Li X
J Cell Physiol; 2018 Jun; 233(6):4801-4814. PubMed ID: 29150946
[TBL] [Abstract][Full Text] [Related]
13. Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
Van der Feen DE; Kurakula K; Tremblay E; Boucherat O; Bossers GPL; Szulcek R; Bourgeois A; Lampron MC; Habbout K; Martineau S; Paulin R; Kulikowski E; Jahagirdar R; Schalij I; Bogaard HJ; Bartelds B; Provencher S; Berger RMF; Bonnet S; Goumans MJ
Am J Respir Crit Care Med; 2019 Oct; 200(7):910-920. PubMed ID: 31042405
[No Abstract] [Full Text] [Related]
14. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.
McMurtry MS; Archer SL; Altieri DC; Bonnet S; Haromy A; Harry G; Bonnet S; Puttagunta L; Michelakis ED
J Clin Invest; 2005 Jun; 115(6):1479-91. PubMed ID: 15931388
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-30c contributes to the development of hypoxia pulmonary hypertension by inhibiting platelet-derived growth factor receptor β expression.
Xing Y; Zheng X; Li G; Liao L; Cao W; Xing H; Shen T; Sun L; Yang B; Zhu D
Int J Biochem Cell Biol; 2015 Jul; 64():155-66. PubMed ID: 25882492
[TBL] [Abstract][Full Text] [Related]
16. Pri-microRNA-124 rs531564 polymorphism minor allele increases the risk of pulmonary artery hypertension by abnormally enhancing proliferation of pulmonary artery smooth muscle cells.
Li Q; Qian Z; Wang L
Int J Chron Obstruct Pulmon Dis; 2017; 12():1351-1361. PubMed ID: 28496318
[TBL] [Abstract][Full Text] [Related]
17. Secretory clusterin is upregulated in rats with pulmonary arterial hypertension induced by systemic-to-pulmonary shunts and exerts important roles in pulmonary artery smooth muscle cells.
Liu X; Meng L; Li J; Meng J; Teng X; Gu H; Hu S; Wei Y
Acta Physiol (Oxf); 2015 Feb; 213(2):505-18. PubMed ID: 25069740
[TBL] [Abstract][Full Text] [Related]
18. Krüppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension.
Courboulin A; Tremblay VL; Barrier M; Meloche J; Jacob MH; Chapolard M; Bisserier M; Paulin R; Lambert C; Provencher S; Bonnet S
Respir Res; 2011 Sep; 12(1):128. PubMed ID: 21951574
[TBL] [Abstract][Full Text] [Related]
19. Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension.
Nakamura K; Sakaguchi M; Matsubara H; Akagi S; Sarashina T; Ejiri K; Akazawa K; Kondo M; Nakagawa K; Yoshida M; Miyoshi T; Ogo T; Oto T; Toyooka S; Higashimoto Y; Fukami K; Ito H
PLoS One; 2018; 13(9):e0203046. PubMed ID: 30180189
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Dysregulation of the Dynamin-Related Protein 1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension: Mechanistic and Therapeutic Implications.
Chen KH; Dasgupta A; Lin J; Potus F; Bonnet S; Iremonger J; Fu J; Mewburn J; Wu D; Dunham-Snary K; Theilmann AL; Jing ZC; Hindmarch C; Ormiston ML; Lawrie A; Archer SL
Circulation; 2018 Jul; 138(3):287-304. PubMed ID: 29431643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
